The Center for Disease Neurogenomics (CDN) is expanding our knowledge of the genetic, cellular, and molecular processes that contribute to neuropsychiatric diseases. The overarching goal of the Center is to promote precision psychiatry by identifying the genetic variants and underlying mechanisms that cause disease and, ultimately, enabling personalized therapy.
We are pioneering new techniques, systems, and processes to advance our goals. The Center studies Alzheimer’s disease, schizophrenia, Parkinson’s disease, bipolar disorder, and other neuropsychiatric and neurodegenerative diseases. These diseases exact an enormous toll—both in terms of quality of life and health care costs—on a broad spectrum of the population.